Back | Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
Misslings public speaking skills (or lack thereof) have | poguemahone | investorshub | 07/19/2024 4:23:55 PM |
We all know blabbering Misleading, when he starts | kund | investorshub | 07/19/2024 4:10:52 PM |
The last Pro (where you wrote n/a) is | Hoskuld | investorshub | 07/19/2024 4:06:19 PM |
https://www.nature.com/articles/s43587-021-00098-4 | KIPK | investorshub | 07/19/2024 3:45:44 PM |
Dr. Marwan has outstanding presentation skills and inspires | jav0033 | investorshub | 07/19/2024 3:45:07 PM |
confident that we going to have a great | longtermbeliever | investorshub | 07/19/2024 3:30:25 PM |
Anavex speakers @AAIC | powerwalker | investorshub | 07/19/2024 3:23:57 PM |
Activation of SG1-mediated autophagy by $AVXL drug could | nidan7500 | investorshub | 07/19/2024 3:09:31 PM |
Surprisingly low volume for this point in the | tschussmann1 | investorshub | 07/19/2024 3:04:11 PM |
I guess I should be keeping better tab | Investor2014 | investorshub | 07/19/2024 3:01:50 PM |
Review Targeting senescent cells in translational medicine | XenaLives | investorshub | 07/19/2024 2:57:54 PM |
Sure...his side gig that he said recently was | Hosai | investorshub | 07/19/2024 2:38:58 PM |
Im referring to the one in Montreal, where | ignatiusrielly35 | investorshub | 07/19/2024 2:37:58 PM |
Perhaps more related to his recent review article. | Doc328 | investorshub | 07/19/2024 2:18:09 PM |
I believe that there will be over 5 | georgejjl | investorshub | 07/19/2024 2:08:39 PM |
Activation of SG1-mediated autophagy by $AVXL drug could | KIPK | investorshub | 07/19/2024 2:08:02 PM |
But still no PR on Anavex related presentation, | kund | investorshub | 07/19/2024 2:07:05 PM |
Careful....You are presenting as regressing to Wolf's age. | LakeshoreLeo1953 | investorshub | 07/19/2024 1:57:47 PM |
Yes but as opposed to the Paris one | Investor2014 | investorshub | 07/19/2024 1:54:22 PM |
I'm in Montreal. I believe he means ND | LakeshoreLeo1953 | investorshub | 07/19/2024 1:50:20 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer's disease patients with good comparative safety profile and no associated neuroimaging adverse events Clinical benefit of blarcamesine consistently observed for both 30 mg and 50 mg treatment groups ...
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...